A study from The University of Texas at San Antonio Health Science Center indicates that changes in the body that lead to ...

ADA: Glucose control in prediabetes cuts diabetes risk Patients with prediabetes who achieve normal glucose regulation, even just one time, have a lower risk for progressing to diabetes. HealthDay ...

You’ve just had your annual blood test, and your doctor gives you the news: You have prediabetes. Before you panic, know that the condition is very common. According to the Centers for Disease Control ...

About The Study: The U.S. Preventive Services Task Force (USPSTF) and the American Diabetes Association (ADA) recently recommended lowering the starting age for diabetes screening to 35 to facilitate ...

Implementing new guidelines would increase screening eligibility and detection of diabetes and prediabetes, according to an analysis published in JAMA. Screening, prevention and treatment of diabetes ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM ...

Even prediabetes seemed to spell bad news for heart health, according to a national inpatient sample study. Prediabetes -- defined as an Hba1c between 5.7% to 6.4% -- among hospitalized patients was ...

An estimated 86 million people in the United States have prediabetes, but they typically have no symptoms. The long-term medical and economic complications of diabetes are significant, costing the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Recommendations for first-line therapy ...

Robin Dorsey’s grandparents, mother, siblings and cousins have all had diabetes. She was the lucky one who escaped the grasp of the chronic disease that’s expected to impact 1 in 3 Americans by 2050 — ...

Prediabetes, as defined by the International Expert Committee (IEC) (A1c 6.0% to < 6.5%), was associated with significantly increased risk for major adverse cardiovascular events (MACE) compared with ...

The revised ADA guidelines state that 2 large clinical trials justify consideration of empagliflozin or liraglutide in patients with established cardiovascular disease to reduce the risk of death. ADA ...